Russia coronavirus vaccine trials: No serious adverse events and elicit antibody response
by Press Release from Outbreak News Today on (#57SJS)
Results from two early-phase Russian non-randomised vaccine trials (Sputnik V) in a total of 76 people are published this week in The Lancet, finding that two formulations of a two-part vaccine have a good safety profile with no serious adverse events detected over 42 days, and induce antibody responses in all participants within 21 days. [...]
The post Russia coronavirus vaccine trials: No serious adverse events and elicit antibody response appeared first on Outbreak News Today.